Study of Neoadjuvant Gemcitabine and Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
Status:
Unknown status
Trial end date:
2015-12-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare induction chemotherapy (gemcitabine+cisplatin) plus
concurrent chemoradiotherapy with concurrent chemoradiotherapy in patients with
locoregionally advanced nasopharyngeal carcinoma (NPC), in order to confirm the value of
induction chemotherapy using gemcitabine and cisplatin in NPC patients.